AKT1 and esophageal squamous cell carcinoma: Therefore, lnc-MCEI was identified as an oncogenic lncRNA in ESCC and could be a potential therapeutic target for ESCC by inhibition of miR-6759-5p/IGF2/PI3K/AKT axis.